Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Exp Clin Transplant ; 21(4): 338-344, 2023 04.
Artículo en Inglés | MEDLINE | ID: mdl-37154593

RESUMEN

OBJECTIVES: Liver transplant represents a widespread therapeutic option for patients with end-stage liver failure. Up to now, most of the scores describing the probability of liver graft survival have shown poor predictive performance. With this in mind, the present study seeks to analyze the predictive value of recipient comorbidities on liver graft survival within the first year. MATERIALS AND METHODS: The study included prospectively collected data from patients who received a liver transplant at our center from 2010 to 2021. A predictive model was then developed through an Artificial Neural Network that included the parameters associated with graft loss as identified by the Spanish Liver Transplant Registry report and comorbidities with prevalence >2% present in our study cohort. RESULTS: Most patients in our study were men (75.5%); mean age was 54.8 ± 9.6 years. The main cause of transplant was cirrhosis (86.7%), and 67.4% of patients had some associated comorbidities. Graft loss due to retransplant or death with dysfunction occurred in 14% of cases. Of all the variables analyzed, we found 3 comorbidities associated with graft loss (as shown by informative value and normalized informative value, respectively): antiplatelet and/or anticoagulants treatments (0.124 and 78.4%), previous immunosuppression (0.110 and 69.6%), and portal thrombosis (0.105 and 66.3%). Remarkably, our model showed a C statistic of 0.745 (95% CI, 0.692-0.798; asymptotic P < .001), which was higher than others found in previous studies. CONCLUSIONS: Our model identified key parameters that may influence graft loss, including specific recipient comorbidities. The use of artificial intelligence methods could reveal connections that may be overlooked by conventional statistics.


Asunto(s)
Enfermedad Hepática en Estado Terminal , Trasplante de Hígado , Masculino , Humanos , Persona de Mediana Edad , Femenino , Supervivencia de Injerto , Inteligencia Artificial , Enfermedad Hepática en Estado Terminal/diagnóstico , Enfermedad Hepática en Estado Terminal/cirugía , Estudios Retrospectivos
2.
Med Clin (Barc) ; 134(14): 624-9, 2010 May 15.
Artículo en Español | MEDLINE | ID: mdl-20202652

RESUMEN

BACKGROUND AND OBJECTIVES: One third of patients with a coronary event show kidney failure. Our aim is to establish the relationship between kidney failure and mortality in patients diagnosed of acute coronary syndrome (ACS) through Cockcroft Index (C-G) and MDRD-4 equation, analyzing which of them is better for prognostic stratification. PATIENTS AND METHOD: Prospective study of 445 patients admitted consecutively between 2006 and 2007 with a high risk of ACS, dividing the sample depending on his kidney function at admission in < 60 mL/min/1.73 m(2) and > or =60 mL/min/1.73 m(2) through C-G and Modification of Diet in Renal Disease study group 4 (MDRD-4) and other variables. We performed a multivariate logistic regression for both of them, analysing the relationship with mortality in the following six months after admission. RESULTS: Renal failure was present in 27.9% (creatinine < 1.1mg/dl); 30.5% (C-G) and 22.6% (MDRD-4). Glomerular filtration (GF) was 81.6+/-35.2 mL/min (C-G) and 77.2+/-26.1 mL/min/1.73 m(2) (MDRD-4). Patients with GF < 60 mL/min showed high mortality, Odds ratio 2.652; p=0.024 (IC 95%, 1.140-6.166) for C-G and 3.372; p=0.001 (IC 95%, 1.637-6.954) for MDRD-4. CONCLUSION: Renal failure increases the risk to die in the following six months after an ACS. The estimation through Cockcroft Index and/or MDRD-4 equation depends on the population characteristics and is indifferent with GF between 60 and 80 mL/min.


Asunto(s)
Síndrome Coronario Agudo/mortalidad , Algoritmos , Tasa de Filtración Glomerular , Insuficiencia Renal/mortalidad , Índice de Severidad de la Enfermedad , Síndrome Coronario Agudo/sangre , Síndrome Coronario Agudo/fisiopatología , Anciano , Anciano de 80 o más Años , Arritmias Cardíacas/epidemiología , Arritmias Cardíacas/fisiopatología , Comorbilidad , Creatinina/sangre , Femenino , Estudios de Seguimiento , Humanos , Estimación de Kaplan-Meier , Modelos Logísticos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Pronóstico , Estudios Prospectivos , Insuficiencia Renal/sangre , Insuficiencia Renal/fisiopatología , Factores de Riesgo
3.
Exp Clin Transplant ; 17(6): 784-791, 2019 12.
Artículo en Inglés | MEDLINE | ID: mdl-31084588

RESUMEN

OBJECTIVES: Scarcity of liver grafts has led to the use of marginal donors, consequently increasing the number of complications posttransplant. To prevent this situation, several indicators have been developed. However, important differences remain among countries. Here, we compared an early-risk liver transplant indicator based on the Spanish Liver Transplant Registry, called the Graft Risk Index, versus the US donor risk index and the Eurotransplant donor risk index. MATERIALS AND METHODS: The new indicator was based on prospectively collected data from 600 adult liver transplants performed in our center. We considered 2 events to compare the indexes: graft survival and rejection-free graft survival, with Cox proportional regression for analyses. Power to predict graft survival was evaluated by calculating the receiver operating characteristic area under the curve. RESULTS: We found no differences between the US and Eurotransplant donor risk indexes in prediction of patients with and without early graft failure. With regard to early survival, only the Graft Risk Index allowed better survival discrimination, in which survival progressively decreased with values ≥ 3 (with probability of graft survival at 1 month of 68%; 95% confidence interval, 46.2-82.5). This increase in risk was significant compared with the standard group (hazard ratio of 10.15; 95% confidence interval, C 3.91- 26.32; P < .001). We calculated powers of prediction of 0.52 (95% confidence interval, 0.43-0.62), 0.54 (95% confidence interval, 0.45-0.65), and 0.69 (95% confidence interval, 0.61-0.77) for donor risk index, Eurotransplant donor risk index, and early Graft Risk Index, respectively. CONCLUSIONS: Neither the US donor risk index nor the Eurotransplant donor risk index was valid for our Spanish liver donation and transplant program. Therefore, an indicator to predict posttransplant graft survival that is adapted to our environment is necessary. This national Graft Risk Index can be a useful tool to optimize donor-recipient matching.


Asunto(s)
Técnicas de Apoyo para la Decisión , Selección de Donante , Rechazo de Injerto/etiología , Supervivencia de Injerto , Trasplante de Hígado/efectos adversos , Complicaciones Posoperatorias/etiología , Donantes de Tejidos/provisión & distribución , Adulto , Anciano , Femenino , Rechazo de Injerto/diagnóstico , Humanos , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/diagnóstico , Valor Predictivo de las Pruebas , Sistema de Registros , Reproducibilidad de los Resultados , Medición de Riesgo , Factores de Riesgo , España , Factores de Tiempo , Resultado del Tratamiento
6.
Med Clin (Engl Ed) ; 157(10): e331-e332, 2021 Nov 26.
Artículo en Inglés | MEDLINE | ID: mdl-34746413
8.
Rev Port Cardiol ; 34(1): 43-50, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25578946

RESUMEN

INTRODUCTION: Ischemic heart disease presents different features in men and women. We analyzed the relation between gender and prognosis in patients who had suffered a high-risk acute coronary syndrome (ACS). METHODS: This was a prospective analytical cohort study performed at Lozano Blesa University Hospital, Zaragoza, Spain, of 559 patients diagnosed with high-risk ACS with and without ST-segment elevation according to the American College of Cardiology/American Heart Association guidelines. The sample was divided into two groups by gender and differences in epidemiologic, laboratory, electrocardiographic and echocardiographic variables and treatment were recorded. A Cox's proportional hazard model was applied and 6-month mortality was analyzed as the main variable. RESULTS: The median age was 65.2±12.7 years, and 21.8% were women. Baseline characteristics in women were more unfavorable, with higher GRACE scores, older age, higher prevalence of hypertension, diabetes and heart failure, lower ejection fraction and more renal dysfunction at admission. Women suffered more adverse cardiovascular events (27.9% vs. 15.8%, p=0.002). Sixty-four patients died, 18.9% of the women vs. 9.4% of the men (p=0.004). After multivariate analysis, female gender did not present an independent relation with mortality. Hemoglobin level, renal function, ejection fraction and Killip class >1 presented significant differences. CONCLUSIONS: Acute syndrome coronary in women has a worse prognosis than in men. Their adverse course is due to their baseline characteristics and not to their gender.


Asunto(s)
Síndrome Coronario Agudo , Caracteres Sexuales , Anciano , Femenino , Humanos , Masculino , Pronóstico
10.
Rev Salud Publica (Bogota) ; 14(4): 657-67, 2012 Aug.
Artículo en Español | MEDLINE | ID: mdl-23912518

RESUMEN

OBJECTIVE: Elderly patients suffering from acute coronary syndrome (ACS) are poorly represented in research and practice clinical guides. This study was aimed at ascertaining characteristics in patients aged older than seventy years having a high risk of ACS. METHODS: This was a prospective and descriptive study of 161 patients aged older than seventy years suffering ACS with and without ST segment elevation and high risk according to ACC/AHA guidelines. Analytic, electrocardiographic, echocardiography and epidemiological variables were included. Mortality and adverse cardiovascular events like post-infarct angina, re-infarct or heart failure were observe dafter six months. RESULTS: Average age was 79.4+3.4 years old; 59.6 % of the sample was male. Arterial hypertension was the most common background (33.5 %). 57.8 % of the patients had an elevated ST segment, 44.7 % having a preserved ejection fraction (>50 %). Most patients had kidney failure (average 61.4+21.8 ml/min/1.73m2 (MDRD-4) and 23.6 % suffered arrhythmia on admission to hospital. 48.4 % of ACS having ST elevation received early reperfusion treatment with fibrinolytic therapy or percutaneous coronary intervention. They had an adverse prognosis as 20.5 % of them suffered stroke and 24.2 % died. CONCLUSION: The ACS profile for people aged older than seventy years consisted of a hypertensive male having suffered previous angina, maintained ejection fraction, kidney failure, high morbimortality and conservative treatment at the time of initial healthcare.


Asunto(s)
Síndrome Coronario Agudo , Síndrome Coronario Agudo/complicaciones , Síndrome Coronario Agudo/terapia , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Estudios Prospectivos , España
11.
Sao Paulo Med J ; 130(4): 259-62, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22965368

RESUMEN

CONTEXT: Decreased vitamin B12 concentration does not usually result in clinical or hematological abnormalities. Subacute combined spinal cord degeneration and pancytopenia are two serious and rarely displayed consequences that appear in severe deficits. CASE REPORT: We present the case of a patient with subacute combined spinal cord degeneration and pancytopenia secondary to severe and sustained vitamin B12 deficiency. Such cases are rare nowadays and have potentially fatal consequences. CONCLUSIONS: Vitamin B12 deficiency should be taken into consideration in the differential diagnosis in cases of blood disorders or severe neurological symptoms. Early diagnosis and treatment can avoid irreversible consequences.


Asunto(s)
Pancitopenia/etiología , Degeneración Combinada Subaguda/etiología , Deficiencia de Vitamina B 12/complicaciones , Humanos , Masculino , Persona de Mediana Edad , Pancitopenia/tratamiento farmacológico , Degeneración Combinada Subaguda/tratamiento farmacológico , Resultado del Tratamiento , Vitamina B 12/uso terapéutico , Deficiencia de Vitamina B 12/tratamiento farmacológico
12.
Med Clin (Barc) ; 139(10): 437-40, 2012 Oct 20.
Artículo en Español | MEDLINE | ID: mdl-22981081

RESUMEN

BACKGROUND AND OBJECTIVE: The cardiorenal syndrome (CRS) includes numerous pathologies affecting the heart and kidney. The objective of this study is to know the characteristics and prognosis of the CRS in patients with acute coronary syndrome (ACS). PATIENTS AND METHOD: A prospective study of 87 patients with ACS with and without ST-segment elevation at high risk and heart failure. We analysed the presence of CRS and its relationship with epidemiological variables, clinical, analytical and complementary explorations. Through a Cox regression model we investigated its relationship with mortality in the subsequent 6 months of the event. RESULTS: Patients with CRS (43.7%) were more frequently women, older, with more prior cardiovascular disease and a profile of higher risk. The prognosis was significantly worse in this group and the CRS was an independent predictor of mortality (hazard ratio 3.08; 95% confidence interval 1.13-8,40; P=.029). CONCLUSIONS: The presence of CRS has an influence in the prognosis of patients who suffer an ACS high-risk and increases the likelihood of dying during 6 months after the event.


Asunto(s)
Síndrome Coronario Agudo/complicaciones , Síndrome Cardiorrenal/complicaciones , Síndrome Coronario Agudo/mortalidad , Factores de Edad , Anciano , Anciano de 80 o más Años , Síndrome Cardiorrenal/diagnóstico , Síndrome Cardiorrenal/mortalidad , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pronóstico , Modelos de Riesgos Proporcionales , Estudios Prospectivos , Factores de Riesgo , Factores Sexuales
13.
Rev. salud pública ; 14(4): 657-667, ago. 2012. tab
Artículo en Español | LILACS | ID: lil-681043

RESUMEN

Objetivos: Los pacientes ancianos que sufren un síndrome coronario agudo (SCA) de alto riesgo están escasamente representados en trabajos de investigación y guías de práctica clínica. El objetivo del trabajo es conocer las características del SCA de alto riesgo en pacientes de >75 años. Métodos: Estudio prospectivo descriptivo de 161 pacientes de >75 años con SCA con y sin elevación del segmento ST de alto riesgo según criterios de la ACA/AHA. Se recogieron variables analíticas, electrocardiográficas, ecocardiográficas y epidemiológicas. Tras seis meses de seguimiento observamos el pronóstico en relación con mortalidad y eventos cardiovasculares adversos (ECVA) de tipo de angorpostinfarto, reinfarto o insuficiencia cardíaca. Resultados: La edad media de edad era de 79,4+3,4 años. El 59,6 % eran varones, La hipertensión arterial era el factor de riesgo cardiovascular más frecuente (65,2 %) y el angor el antecedente más común (33,5 %). El 57,8 % presentaban elevación del segmento ST y predominaba la fracción de eyección conservada (>50 %): 44,7 %. La mayoría presentaban algún grado de disfunción renal con media de: 61,4+21,8 ml/min/1,73m2(MDRD-4). El 23,6 % sufrían arritmias durante el ingreso. El tratamiento de reperfusión precoz con trombolíticos y/o intervencionismo coronario percutáneo en el SCACEST fue de un 48,4 %. El pronóstico era adverso, 20,5 % sufrían algún ECVA y fallecían el 24,2 %. Conclusión: El perfil del SCA en pacientes de 75 años y más es un varón hipertenso, con angor previo, fracción de eyección conservada, deterioro de la función renal, alta morbimortalidad y tratamiento inicial conservador.


Objective: Elderly patients suffering from acute coronary syndrome (ACS) are poorly represented in research and practice clinical guides. This study was aimed at ascertaining characteristics in patients aged older than seventy years having a high risk of ACS. Methods: This was a prospective and descriptive study of 161 patients aged older than seventy years suffering ACS with and without ST segment elevation and high risk according to ACC/AHA guidelines. Analytic, electrocardiographic, echocardiography and epidemiological variables were included. Mortality and adverse cardiovascular events like post-infarct angina, re-infarct or heart failure were observe dafter six months. Results: Average age was 79.4+3.4 years old; 59.6 % of the sample was male. Arterial hypertension was the most common background (33.5 %). 57.8 % of the patients had an elevated ST segment, 44.7 % having a preserved ejection fraction (>50 %). Most patients had kidney failure (average 61.4+21.8 ml/min/1.73m2 (MDRD-4) and 23.6 % suffered arrhythmia on admission to hospital. 48.4 % of ACS having ST elevation received early reperfusion treatment with fibrinolytic therapy or percutaneous coronary intervention. They had an adverse prognosis as 20.5 % of them suffered stroke and 24.2 % died. Conclusion: The ACS profile for people aged older than seventy years consisted of a hypertensive male having suffered previous angina, maintained ejection fraction, kidney failure, high morbimortality and conservative treatment at the time of initial healthcare.


Asunto(s)
Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Síndrome Coronario Agudo , Síndrome Coronario Agudo/complicaciones , Síndrome Coronario Agudo/terapia , Estudios Prospectivos , España
15.
São Paulo med. j ; 130(4): 259-262, 2012. ilus, tab
Artículo en Inglés | LILACS | ID: lil-647953

RESUMEN

CONTEXT: Decreased vitamin B12 concentration does not usually result in clinical or hematological abnormalities. Subacute combined spinal cord degeneration and pancytopenia are two serious and rarely displayed consequences that appear in severe deficits. CASE REPORT: We present the case of a patient with subacute combined spinal cord degeneration and pancytopenia secondary to severe and sustained vitamin B12 deficiency. Such cases are rare nowadays and have potentially fatal consequences. CONCLUSIONS: Vitamin B12 deficiency should be taken into consideration in the differential diagnosis in cases of blood disorders or severe neurological symptoms. Early diagnosis and treatment can avoid irreversible consequences.


CONTEXTO: El descenso de la concentración de vitamina B12 no suele derivar en alteraciones clínicas o hematológicas. La degeneración combinada subaguda medular y la pancitopenia son dos consecuencias graves y poco frecuentes que aparecen en los déficit severos. CASO CLÍNICO: Presentamos el caso de un paciente con una degeneración combinada subaguda medular y pancitopenia secundarios a un déficit severo y mantenido de vitamina B12. Un caso poco común en nuestros días y con consecuencias potencialmente fatales. CONCLUSIONES: Debemos considerar el déficit de vitamina B12 dentro del diagnóstico diferencial en caso de alteraciones hematológicas o síntomas neurológicos graves. Su diagnóstico y tratamento precoz pueden evitar secuelas irreversibles.


Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Pancitopenia/etiología , Degeneración Combinada Subaguda/etiología , /complicaciones , Pancitopenia/tratamiento farmacológico , Degeneración Combinada Subaguda/tratamiento farmacológico , Resultado del Tratamiento , /tratamiento farmacológico , /uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA